Cogent Biosciences, Inc. COGT
- CGT4859 — Cholangiocarcinoma Phase 1
FGFR2 (2 companies · 2 programs)
Companies with an active program directed at FGFR2.
Tyra Biosciences, Inc. TYRA
- TYRA-200 — Intrahepatic Cholangiocarcinoma Phase 1
Companies with an active program directed at FGFR2.